Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tissue-derived tumor growth inhibitor

Tissue-derived tumor growth inhibitor

US Patent 6586394 · Granted Jul 1, 2003

Estimated economic value: $27,339,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pulse dosing regimen and methods of treatment2023
Therapeutic and cosmetic uses and applications of calreticulin2023
Pulse dosing regimen and methods of treatment2022
Therapeutic and cosmetic uses and applications of calreticulin2021
Pulse dosing regimen and methods of treatment2020
Therapeutic and cosmetic uses and applications of calreticulin2019
Recombinant VapA and VapC peptides and uses thereof2018
Generation of native recombinant secreted human endoplasmic reticulum chaperones2017
Method of treating cancer with modulators of SCFSkp22016
Therapeutic and cosmetic uses and applications of calreticulin2016
Methods for treating diabetic wounds2015
Methods for treating diabetic wounds2012